PLIANT THERAPEUTICS INC's ticker is PLRX and the CUSIP is 729139105. A total of 78 filers reported holding PLIANT THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.6%.
Links
Filings
- All filings
- Annual reports (20-F)
- Quarterly reports (6-K)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,695,741 | +8469.7% | 270,804 | +8855.2% | 0.00% | – |
| Q2 2023 | $54,795 | -85.9% | 3,024 | -79.2% | 0.00% | – |
| Q1 2023 | $387,296 | +271.4% | 14,560 | +169.9% | 0.00% | – |
| Q4 2022 | $104,286 | -24.4% | 5,395 | -18.3% | 0.00% | – |
| Q3 2022 | $138,000 | +392.9% | 6,600 | +86.6% | 0.00% | – |
| Q2 2022 | $28,000 | +33.3% | 3,537 | +18.4% | 0.00% | – |
| Q1 2022 | $21,000 | -85.0% | 2,987 | -71.1% | 0.00% | – |
| Q4 2021 | $140,000 | +337.5% | 10,321 | +434.8% | 0.00% | – |
| Q3 2021 | $32,000 | -22.0% | 1,930 | +38.2% | 0.00% | – |
| Q2 2021 | $41,000 | +17.1% | 1,397 | +55.9% | 0.00% | – |
| Q1 2021 | $35,000 | +9.4% | 896 | -35.0% | 0.00% | – |
| Q4 2020 | $32,000 | -43.9% | 1,379 | -45.1% | 0.00% | – |
| Q3 2020 | $57,000 | – | 2,510 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 339,160 | $5,881,034 | 100.00% |
| CHI Advisors LLC | 3,014,199 | $52,266,211 | 20.72% |
| TRV GP IV, LLC | 2,132,867 | $36,983,914 | 13.93% |
| GREAT POINT PARTNERS LLC | 1,755,184 | $30,434,891 | 5.54% |
| First Light Asset Management, LLC | 2,933,260 | $50,862,728 | 4.83% |
| Deep Track Capital, LP | 5,500,000 | $95,370,000 | 3.68% |
| Casdin Capital, LLC | 1,577,108 | $27,347,053 | 3.03% |
| Fernwood Investment Management, LLC | 379,702 | $6,584,033 | 2.37% |
| Redmile Group, LLC | 2,678,099 | $46,438,237 | 2.21% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 250,409 | $4,342,092 | 1.32% |